We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current SGBI market cap is 314.85k. The company's latest EPS is USD -0.0007 and P/E is 0.00.
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Revenue | 88k | 29k | 66k | 69k | 93k |
Operating Income | -340k | -188k | -151k | -140k | -88k |
Net Income | -324k | -193k | -199k | -59k | -148k |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Total Assets | 79k | 125k | 134k | 131k | 91k |
Total Liabilities | 671k | 855k | 1.01M | 1.03M | 1.13M |
Total Equity | -592k | -730k | -875k | -895k | -1.04M |
Year End June 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
Operating | -317k | -168k | -146k | -140k | -12k |
Investing | N/A | -3k | N/A | N/A | N/A |
Financing | 326k | 159k | 162k | 142k | N/A |
Market Cap | 314.85k |
Price to Earnings Ratio | 0.00 |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 209.9M |
Average Volume (1 week) | 0 |
Average Volume (1 Month) | 0 |
52 Week Change | -65.12% |
52 Week High | 0.02 |
52 Week Low | 0.0012 |
Spread (Intraday) | 0 (0%) |
Company Name | Sangui Biotech International Inc (CE) |
Address |
291 south 200 west farmington, delaware 84025 |
Website | https://www.sanguibiotech.com |
Industry | medicinal chems,botanicl pds (2833) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions